Iconic Labs PLC (LSE:ICON) announced a strategic shift towards seeking a reverse takeover (RTO) target, marking a change from the initial plan, which was to establish a strategic advisory services business.
This move follows the appointment of Victor Humberdot and Bela Lendvai-Lintner as non-executive directors, succeeding Marija Hrebac, David Stybr and Emmanuel Blouin.
Humberdot, an experienced investment banker and founder of HUVI Capital, and Lendvai-Lintner, a partner at ARX Equity Partners, bring valuable expertise to the board.
The shares were up 3% at 3.6p; however, Iconic is valued at just £371,000.